The Ontario government has narrowed its out-of-country drug funding rules following a court victory by a cancer patient. The policy change affects public funding access for medical treatments obtained outside of Canada.
The regulatory shift comes in direct response to the legal efforts of an Ontario resident diagnosed with Stage 4 melanoma. According to the patient, the newly tightened provincial rules have effectively blocked his access to funding for urgent drug therapies sought in the United States.
In-depth summary · AI, neutral